首页> 外文期刊>Drug Design, Development and Therapy >Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
【24h】

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells

机译:咖啡和咖啡因可通过抑制N2a / APP细胞中的Aβ寡聚化和调节Tau介导的途径来增强褪黑激素的抗淀粉样变性活性。

获取原文
           

摘要

Abstract: There is an increasing prevalence of Alzheimer’s disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the current therapeutic drugs cannot produce acceptable efficacy in AD patients. Previous animal studies have shown that coffee (Coff), caffeine (Caff), and melatonin (Mel) have beneficial effects on AD. Disturbed circadian rhythms are observed in AD, and chronotherapy has shown promising effects on AD. In this study, we examined whether a combination of Coff or Caff plus Mel produced a synergistic/additive effect on amyloid-? (A?) generation in Neuro-2a (N2a)/amyloid precursor protein (APP) cells and the possible mechanisms involved. Cells were treated with Coff or Caff, with or without combined Mel, with three different chronological regimens. In regimen 1, cells were treated with Coff or Caff for 12?hours in the day, followed by Mel for 12 hours in the night. For regimen 2, cells were treated with Coff or Caff plus Mel for 24 hours, from 7 am to 7 am the next day. In regimen 3, cells were treated with Coff or Caff plus Mel with regimen 1 or 2 for 5 consecutive days. The extracellular Aβ40/42 and Aβ oligomer levels were determined using enzyme-linked immunosorbent assay (ELISA) kits. The?expression and/or phosphorylation levels of glycogen synthase kinase 3β (GSK3β), Erk1/2, PI3K, Akt, Tau, Wnt3α, β-catenin, and Nrf2 were detected by Western blot assay. The results showed that regimen 1 produced an additive antiamyloidogenic effect with significantly reduced extracellular levels of Aβ40/42 and Aβ42 oligomers. Regimen 2 did not result in remarkable effects, and regimen 3 showed a less antiamyloidogenic effect compared to regimen 1. Coff or Caff, plus Mel reduced oxidative stress in N2a/APP cells via the Nrf2 pathway. Coff or Caff, plus Mel inhibited GSK3β, Akt, PI3K p55, and Tau phosphorylation but enhanced PI3K p85 and Erk1/2 phosphorylation in N2a/APP cells. Coff or Caff, plus Mel downregulated Wnt3α expression but upregulated β-catenin. However, Coff or Caff plus Mel did not significantly alter the production of T helper cell (Th)1-related interleukin (IL)-12 and interferon (IFN)-γ and Th2-related IL-4 and IL-10 in N2a/APP cells. The autophagy of cells was not affected by the combinations. Taken together, combination of Caff or Coff, before treatment with Mel elicits an additive antiamyloidogenic effects in N2a/APP cells, probably through inhibition of Aβ oligomerization and modulation of the Akt/GSK3β/Tau signaling pathway.
机译:摘要:阿尔茨海默氏病(AD)的患病率正在上升,这已成为公共卫生问题。然而,AD发病机理的基本机制尚未完全了解,并且当前的治疗药物不能在AD患者中产生可接受的功效。先前的动物研究表明,咖啡(Coff),咖啡因(Caff)和褪黑激素(Mel)对AD具有有益作用。在AD中观察到昼夜节律紊乱,并且计时疗法对AD显示出有希望的作用。在这项研究中,我们检查了Coff或Caff加Mel的组合是否对淀粉样蛋白产生了协同/累加作用。 Neuro-2a(N2a)/淀粉样前体蛋白(APP)细胞中(Aβ)的产生及其可能的机制。用Coff或Caff,结合或不结合Mel,以三种不同的时间顺序方案处理细胞。在方案1中,白天将细胞用Coff或Caff处理12个小时,然后在晚上用Mel处理12个小时。对于方案2,从第二天上午7点至第二天早上7点,将细胞用Coff或Caff加Mel进行24小时处理。在方案3中,连续5天用Coff或Caff加Mel与方案1或2处理细胞。使用酶联免疫吸附测定(ELISA)试剂盒测定细胞外Aβ40/ 42和Aβ寡聚物水平。通过蛋白质印迹法检测糖原合酶激酶3β(GSK3β),Erk1 / 2,PI3K,Akt,Tau,Wnt3α,β-catenin和Nrf2的表达和/或磷酸化水平。结果表明,方案1产生了附加的抗淀粉样蛋白生成作用,并显着降低了细胞外Aβ40/ 42和Aβ42寡聚物的水平。方案2并未产生明显的作用,与方案1相比,方案3的抗淀粉样蛋白生成作用较小。Coff或Caff,加上Mel通过Nrf2途径降低了N2a / APP细胞的氧化应激。 Coff或Caff加上Mel可抑制N2a / APP细胞中的GSK3β,Akt,PI3K p55和Tau磷酸化,但增强PI3K p85和Erk1 / 2磷酸化。 Coff或Caff,再加上Mel,下调Wnt3α表达,但上调β-catenin。但是,Coff或Caff加Mel不明显改变N2a /中T辅助细胞(Th)1相关白介素(IL)-12和干扰素(IFN)-γ和Th2相关IL-4和IL-10的产生。 APP单元。细胞的自噬不受组合的影响。综上所述,在用Mel处理之前,将Caff或Coff组合可能在N2a / APP细胞中引起附加的抗淀粉样蛋白作用,可能是通过抑制Aβ寡聚和调节Akt /GSK3β/ Tau信号通路来实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号